| 2022 | Real-world data on prognostic value of measurable residual disease assessment by fragment analysis or next-generation sequencing in multiple myeloma | BRITISH JOURNAL OF HAEMATOLOGY |
| 2022 | Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma
| SCIENTIFIC REPORTS |
| 2022 | Predictive Factors of Event-Free Survival at 24 Months in Patients with Peripheral T-Cell Lymphoma: A Retrospective Study
| CANCER RESEARCH AND TREATMENT |
| 2022 | Ig Gene Clonality Analysis Using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma Patients
| JOURNAL OF MOLECULAR DIAGNOSTICS |
| 2021 | Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea
| BLOOD RESEARCH |
| 2021 | Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study | ANNALS OF HEMATOLOGY |
| 2021 | Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: a randomized phase 3 study
| BLOOD ADVANCES |
| 2021 | 다발골수종 및 관련 형질세포 질환의 조기 진단을 위한 선별 검사
| Korean Journal of Medicine |
| 2021 | 국내 임상시험 및 대상자 보호프로그램 도입 현황과 안전관리체계에 대한 설문조사 연구
| Journal of Korean association of IRB |
| 2021 | Risk factors for neutropenic fever in non-Hodgkin's lymphoma patients with primary granulocyte colony-stimulating factor prophylaxis
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2021 | Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial | ANNALS OF HEMATOLOGY |
| 2021 | Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis | NEW ENGLAND JOURNAL OF MEDICINE |
| 2021 | Association between body image dissatisfaction and poor quality of life and depression among patients with hematopoietic stem cell transplantation | SUPPORTIVE CARE IN CANCER |
| 2021 | Clinical characteristics and prognostic factors of acquired haemophilia A in Korea | HAEMOPHILIA |
| 2021 | Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma | BONE MARROW TRANSPLANTATION |
| 2021 | Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma | CLINICAL CANCER RESEARCH |
| 2021 | Combination treatment of copanlisib and gemcitabine in relapsed/refractory PTCL (COSMOS): an open-label phase I/II trial
| ANNALS OF ONCOLOGY |
| 2021 | Safety, pharmacokinetics, and pharmacodynamics of a next-generation subcutaneously administered coagulation factor IX variant, dalcinonacog alfa, in previously treated hemophilia B patients | JOURNAL OF THROMBOSIS AND HAEMOSTASIS |
| 2021 | Updated recommendations for the treatment of venous thromboembolism
| BLOOD RESEARCH |
| 2021 | Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients
| JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION |
| 2021 | Arsenic trioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in acute myeloid leukaemia cells
| EXPERIMENTAL HEMATOLOGY & ONCOLOGY |
| 2021 | Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin's lymphoma
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2021 | Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study
| JOURNAL OF HEMATOLOGY & ONCOLOGY |
| 2021 | Impact of depression on adherence to lenalidomide plus low-dose dexamethasone in patients with relapsed or refractory myeloma | SUPPORTIVE CARE IN CANCER |
| 2021 | Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone | INTERNATIONAL JOURNAL OF HEMATOLOGY |
| 2021 | Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas | ANNALS OF HEMATOLOGY |
| 2021 | Treatment outcome and prognostic factors of Korean patients with chronic lymphocytic leukemia: a multicenter retrospective study
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2020 | Human herpesvirus 8-negative effusion-based lymphoma with indolent clinical behavior in an elderly patient: A case report and literature review
| ONCOLOGY LETTERS |
| 2020 | Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX
| BLOOD CANCER JOURNAL |
| 2020 | Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis | LEUKEMIA & LYMPHOMA |
| 2020 | Distinct genetic profile with recurrent population-specific missense variants in Korean adult atypical hemolytic uremic syndrome | THROMBOSIS RESEARCH |
| 2020 | Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database
| CANCER RESEARCH AND TREATMENT |
| 2020 | Immunosuppressive role of CD11b + CD33 + HLA-DR - myeloid-derived suppressor cells-like blast subpopulation in acute myeloid leukemia
| CANCER MEDICINE |
| 2020 | Upfront autologous hematopoietic stem cell transplantation for high-risk patients with double-expressor diffuse large B cell lymphoma | ANNALS OF HEMATOLOGY |
| 2020 | First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial
| CANCERS |
| 2020 | Association between sexuality knowledge and sexual dysfunction in hematopoietic stem cell transplantation patients and their partners | PATIENT EDUCATION AND COUNSELING |
| 2020 | Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL) | BONE MARROW TRANSPLANTATION |
| 2020 | Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era
| SCIENTIFIC REPORTS |
| 2020 | Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 study | INTERNATIONAL JOURNAL OF HEMATOLOGY |
| 2020 | Serum albumin and C-reactive protein as significant predictors of non-relapse mortality in lower gastrointestinal graft-versus-host disease | ANNALS OF HEMATOLOGY |
| 2020 | ULK1 Inhibition as a Targeted Therapeutic Strategy for FLT3-ITD-mutated Acute Myeloid Leukemia
| JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
| 2020 | Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study)
| AMERICAN JOURNAL OF HEMATOLOGY |
| 2020 | Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial
| CANCER RESEARCH AND TREATMENT |
| 2020 | PERK/NRF2 and Autophagy Form a Resistance Mechanism Against G9a Inhibition in Leukemia Stem Cells
| JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
| 2020 | The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria | BLOOD |
| 2020 | The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study) | ANNALS OF HEMATOLOGY |
| 2020 | A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma | ANNALS OF HEMATOLOGY |
| 2020 | Analysis of the Efficacy of Thalidomide Plus Dexamethasone-Based Regimens in Patients With Relapsed/Refractory Multiple Myeloma Who Received Prior Chemotherapy, Including Bortezomib and Lenalidomide: KMM-166 Study | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA |
| 2020 | Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2019 | Clinical Implication of Renal Dysfunction During the Clinical Course in Patients With Paroxysmal Nocturnal Hemoglobinuria: A Longitudinal Analysis | ANNALS OF HEMATOLOGY |
http://orcid.org/0000-0001-8986-8436
(55032033600)
